Immune Reconstitution Strategies in HIV.
Curr Infect Dis Rep., Jun;3(3):302-308 (2001)
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients.
Hum. Gene Ther., Mar;15(3):251-62 (2004)
Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes.
J. Immunol., Nov;181(10):7400-6 (2008)
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.
Nat. Med., Mar;15(3):285-92 (2009)
Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt.
Stem Cells Int., 2011:393698 (2011)
Recombinant human granulocyte colony-stimulating factor increases circulating burst forming unit-erythron and red blood cell production in patients with severe human immunodeficiency virus infection.
Blood., Jun;75(11):2137-42 (1990)
AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.
Proc. Natl. Acad. Sci. U.S.A., Jun;87(11):4068-72 (1990)
Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
Br. J. Haematol., Oct;79 Suppl 1:69-73 (1991)
Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias.
Blood., Dec;78(12):3200-8 (1991)
Improved survival for patients with AIDS-related Kaposi's sarcoma.
J. Clin. Oncol., Sep;12(9):1910-6 (1994)
Gene therapy for the treatment of AIDS: animal models and human clinical experience.
Front. Biosci., May;4:D468-75 (1999)
Update on the pathogenesis and treatment of Kaposi sarcoma.
Curr Opin Oncol., Mar;12(2):174-80 (2000)
A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme.
Hum. Gene Ther., Sep;10(13):2255-70 (1999)
Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients.
Proc. Natl. Acad. Sci. U.S.A., Apr;85(8):2763-6 (1988)
Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma.
J. Acquir. Immune Defic. Syndr., 2(1):54-8 (1989)
The use of myeloid hematopoietic growth factors in patients with HIV infection.
Int. J. Cell Cloning., Jan;8 Suppl 1:347-54; discussion 354-5 (1990)
Phenotypically defined memory CD4+ cells are not selectively decreased in chronic HIV disease.
J. Acquir. Immune Defic. Syndr., Jul;7(7):665-75 (1994)
Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection.
J. Infect. Dis., Apr;179(4):843-8 (1999)
Gamma-interferon-induced monocyte major histocompatibility complex class II antigen expression individuals with acquired immune deficiency syndrome.
Cell. Immunol., Oct;123(2):316-24 (1989)
Hematopoietic growth factors in the treatment of patients with HIV infection.
Biotherapy., 2(2):173-81 (1990)